Although hyperferritinemia may be reflective of elevated total body iron stores, there are conditions in which ferritin levels are disproportionately elevated relative to iron status. Autosomal dominant forms of hyperferritinemia due to mutations in the L2ferritin IRE or in A helix of L2ferritin gene have been described, however cases of isolated hyperferritinemia still remain unsolved. We describe 12 Italian subjects with unexplained isolated hyperferritinemia (UIH). Four probands have affected siblings, but no affected parents or offspring. Sequencing analyses did not identify casual mutations in ferritin gene or IRE regions. These patients had normal levels of intracellular ferritin protein and mRNA in peripheral blood cells excluding pathological ferritin production at transcriptional and post-transcriptional level. In contrast with individuals with benign hyperferritinemia caused by mutations affecting the ferritin A helix, low rather than high glycosylation of serum ferritin was observed in our UIH subjects compared with controls. These findings suggest that subjects with UIH have a previously undescribed form of hyperferritinemia possibly attributable to increased cellular ferritin secretion and/or decreased serum ferritin clearance. The cause remains to be defined and we can only speculate the existence of mutations in gene/s not directly implicated in iron metabolism that could affect ferritin turnover including ferritin secretion.
| I N T R O D U C T I O N
Ferritin is a ubiquitous protein able to store iron in the cell cytosol. The cytosolic ferritin consists of two subunits, the Light chain (L-ferritin) and the Heavy chain (H-ferritin) that assemble in different proportion to form apo-ferritin shells. Ferritin nanocages are made of 24 subunits of L and H chains that create a cavity where intracellular iron is collected. The stored iron is released and made available to cellular need by ferritin degradation. 1 Ferritin can bind, oxide and store up to 4500 atoms of Fe (II), preventing iron-mediated oxidative stress. 2, 3 This is accomplished by regulating ferritin synthesis according to cell iron content and oxidative stress at both post-transcriptional [through the iron responsive element (IRE)-iron regulatory protein system] and transcriptional level. 4 Small amount of ferritin are present in the blood and consist of ferritin L, a glycosylated form of L termed ferritin G, [5] [6] [7] and trace amounts of ferritin H. 8 It is mainly secreted from macrophages, 9 by hepatocytes, 10, 11 and lymphoid cells, 12 but most aspects of its secretion remain unknown. Serum ferritin has a wide clinical utility primarily as an indicator of intracellular iron stores. [13] [14] [15] However, causes of raised serum ferritin are numerous, including primary and secondary iron overload disorders, but also conditions where serum ferritin is disproportionally increased relative to body iron stores such as chronic liver diseases, inflammatory and metabolic disorders that are frequently observed in the clinical setting. 16, 17 Thus, the diagnosis of hyperferritinemia requires a systematic strategy including personal and family his- 
| Isolation of mononuclear cells from peripheral blood and measurement of intracellular ferritin

| Statistical analysis
Data were expressed as median and 1st-3rd quartile. Nonparametric One-way ANOVA followed by Dunn test was used to compare more than two groups. All tests were two sided and with a significance level of a 5 0.05. Analyses were carried out by the GRAPHPAD PRISM statistical analysis software (version 3.02; GraphPad Software, La Jolla, CA).
| R E S U L T S 3.1 | Iron indices
Biochemical and clinical data of patients with UIH at diagnosis are reported in Table 1 . Age and iron indices did not differ between probands and siblings, therefore they were considered together in subsequent analyses. In particular, probands and their siblings had comparable levels of serum ferritin concentration (Spearman r 5 0.80).
None of the available UIH probands' parents (N 5 5) and offspring (N 5 11) had hyperferritinemia. Although hepcidin values showed a wide range of variability, it was significantly higher in UIH patients than in controls, but not higher than in HHCS. There were no correlations between serum hepcidin and the other variables considered (serum iron indices, liver function tests, cholesterol, triglycerides, glycemia, hemoglobin, insulinemia and body mass index, and CRP) in UIH patients. Figure 1 shows intracellular ferritin content in lympho-monocytes (LFM) and RBC of UIH patients, subjects with HHCS and controls. RBC L-and H-ferritin did not significant differ between UIH patients and controls. As expected, intracellular levels of L-ferritin in both RBC and LFM were significantly higher in HHCS than in UIH patients while Hferritin levels were lower in HHCS compared with UIH patients.
| DNA analysis
| Ferritin content in lympho-monocytes and RBC
| Ferritin mRNA levels in lympho-monocytes
We measured mRNA levels of L and H ferritin in 9 UIH patients and 6
controls. We did not observed significant differences between UIH 
| Serum ferritin glycosylation
Percentage of glycosylated ferritin in serum was significantly lower in UIH patients and HHCS subjects compared to controls or HFE-HH subjects while no differences were observed between UIH patients and HHCS subjects (Figure 2 ).
| DISCUSSION
In this article, we described 12 Italian patients (8 probands and 4 sib- Despite a large variability, hepcidin levels were increased in UIH patients compared to healthy controls. Disorders known to be able to induce hepcidin synthesis were excluded "a priori" and confirmed by the absence of correlation between metabolic, hepatic, and inflammatory parameters and serum hepcidin levels. Experimental studies performed in mice showed that exogenous human liver ferritin increased the hepatic expression of Hamp1 mRNA in association with the increase in Bmp6 mRNA 28 suggesting that circulating ferritin might serve as the signaling molecule of iron stores. Although our findings need to be confirmed, they might give support to the hypothesis of a "positive-feedback" loop between serum ferritin and hepcidin. Interestingly, we also observed higher hepcidin levels in HHCS patients although the small number of patients studied does not allow adequate statistical evaluation. A previous study analyzed serum hepcidin in six subjects with HHCS showing no significant differences compared with a group of healthy controls not matched for sex and age. 29 Thus, more rigorous studies in larger age-and sex-matched cohorts, using validate hepcidin assays, are needed. to the glycation of hemoglobin in RBCs and a lysosomal pathway of ferritin secretion. 9 It cannot be excluded that both pathways are available and variably operates in different clinical conditions or in different cell lines. 9, 34 We had no explanation of the relatively low level of glycosylation of serum ferritin in our UIH patients, and we cannot speculate whether this has some role in causing hyperferritinemia or is a mere observation void of physio-pathological importance. However, this finding together with the lack of L-ferritin gene mutations and the evidence of a hypothetical recessive pattern of transmission mark clear differences between this form of "benign" hyperferritinemia and that recently described by Kannengiesser et al. and Thurlow et al. 19, 20 In conclusion, this is the first report of patients with unexplained hyperferritinemia not associated with iron overload possibly inherited as a recessive trait. The cause remains to be defined and we can only speculate the existence of mutations in gene/s not directly implicated in iron metabolism that could affect ferritin turnover including ferritin secretion. Indeed, mechanisms of ferritin secretion are still unclear as well as the role of circulating ferritin and mechanisms of serum ferritin clearance or degradation. Further studies could clarify serum ferritin metabolism and possibly identify candidate proteins and genes involved in this process.
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